Burrill & Company

Pharma

North Carolina pharma R&D funding: A snapshot of 2010

Research and development spending dollars reached a record $67.4 billion in 2010, a $1.5 billion increase compared with 2009. North Carolina’s life science companies are certainly part of that mix. A look at the annual reports from public companies in the state shows that many of them are indeed pouring money into R&D. The U.S. […]

MedCity Influencers

Burrill & Co., Infinity Group to invest in China

Burrill & Co. and the Infinity Group are joining forces to pursue investments in Chinese life science companies. San Francisco-based Burrill, a venture capital/private equity player that's also trying to launch a $1 billion investment fund in Minnesota, and Israel- and China-based Infinity will co-invest in U.S. dollars and Chinese renminbi as equal partners, according to a press release.